690 related articles for article (PubMed ID: 29709653)
1. Oleic acid protects saturated fatty acid mediated lipotoxicity in hepatocytes and rat of non-alcoholic steatohepatitis.
Chen X; Li L; Liu X; Luo R; Liao G; Li L; Liu J; Cheng J; Lu Y; Chen Y
Life Sci; 2018 Jun; 203():291-304. PubMed ID: 29709653
[TBL] [Abstract][Full Text] [Related]
2. Oleic acid improves hepatic lipotoxicity injury by alleviating autophagy dysfunction.
Liu X; Li X; Su S; Yuan Y; Liu W; Zhu M; Zheng Q; Zeng X; Fu F; Lu Y; Chen Y
Exp Cell Res; 2023 Aug; 429(2):113655. PubMed ID: 37253404
[TBL] [Abstract][Full Text] [Related]
3. Oleic acid protects insulin-secreting INS-1E cells against palmitic acid-induced lipotoxicity along with an amelioration of ER stress.
Liu X; Zeng X; Chen X; Luo R; Li L; Wang C; Liu J; Cheng J; Lu Y; Chen Y
Endocrine; 2019 Jun; 64(3):512-524. PubMed ID: 30778898
[TBL] [Abstract][Full Text] [Related]
4. Oleic acid ameliorates palmitic acid induced hepatocellular lipotoxicity by inhibition of ER stress and pyroptosis.
Zeng X; Zhu M; Liu X; Chen X; Yuan Y; Li L; Liu J; Lu Y; Cheng J; Chen Y
Nutr Metab (Lond); 2020; 17():11. PubMed ID: 32021639
[TBL] [Abstract][Full Text] [Related]
5. Myristic acid potentiates palmitic acid-induced lipotoxicity and steatohepatitis associated with lipodystrophy by sustaning de novo ceramide synthesis.
Martínez L; Torres S; Baulies A; Alarcón-Vila C; Elena M; Fabriàs G; Casas J; Caballeria J; Fernandez-Checa JC; García-Ruiz C
Oncotarget; 2015 Dec; 6(39):41479-96. PubMed ID: 26539645
[TBL] [Abstract][Full Text] [Related]
6. 3-Acetyl-oleanolic acid ameliorates non-alcoholic fatty liver disease in high fat diet-treated rats by activating AMPK-related pathways.
Ou-Yang Q; Xuan CX; Wang X; Luo HQ; Liu JE; Wang LL; Li TT; Chen YP; Liu J
Acta Pharmacol Sin; 2018 Aug; 39(8):1284-1293. PubMed ID: 29345253
[TBL] [Abstract][Full Text] [Related]
7. Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells.
Chong LW; Hsu YC; Lee TF; Lin Y; Chiu YT; Yang KC; Wu JC; Huang YT
BMC Gastroenterol; 2015 Feb; 15():22. PubMed ID: 25886887
[TBL] [Abstract][Full Text] [Related]
8. The role of hepassocin in the development of non-alcoholic fatty liver disease.
Wu HT; Lu FH; Ou HY; Su YC; Hung HC; Wu JS; Yang YC; Wu CL; Chang CJ
J Hepatol; 2013 Nov; 59(5):1065-72. PubMed ID: 23792031
[TBL] [Abstract][Full Text] [Related]
9. The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis.
Barreyro FJ; Holod S; Finocchietto PV; Camino AM; Aquino JB; Avagnina A; Carreras MC; Poderoso JJ; Gores GJ
Liver Int; 2015 Mar; 35(3):953-66. PubMed ID: 24750664
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effect and autophagy regulation of myriocin in nonalcoholic steatohepatitis.
Yang RX; Pan Q; Liu XL; Zhou D; Xin FZ; Zhao ZH; Zhang RN; Zeng J; Qiao L; Hu CX; Xu GW; Fan JG
Lipids Health Dis; 2019 Oct; 18(1):179. PubMed ID: 31639005
[TBL] [Abstract][Full Text] [Related]
11. Palmitic acid induces autophagy in hepatocytes via JNK2 activation.
Tu QQ; Zheng RY; Li J; Hu L; Chang YX; Li L; Li MH; Wang RY; Huang DD; Wu MC; Hu HP; Chen L; Wang HY
Acta Pharmacol Sin; 2014 Apr; 35(4):504-12. PubMed ID: 24608675
[TBL] [Abstract][Full Text] [Related]
12. Hesperetin ameliorates hepatic oxidative stress and inflammation
Li J; Wang T; Liu P; Yang F; Wang X; Zheng W; Sun W
Food Funct; 2021 May; 12(9):3898-3918. PubMed ID: 33977953
[TBL] [Abstract][Full Text] [Related]
13. Glycine protects against high sucrose and high fat-induced non-alcoholic steatohepatitis in rats.
Zhou X; Han D; Xu R; Wu H; Qu C; Wang F; Wang X; Zhao Y
Oncotarget; 2016 Dec; 7(49):80223-80237. PubMed ID: 27784003
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of NAMPT aggravates high fat diet-induced hepatic steatosis in mice through regulating Sirt1/AMPKα/SREBP1 signaling pathway.
Wang LF; Wang XN; Huang CC; Hu L; Xiao YF; Guan XH; Qian YS; Deng KY; Xin HB
Lipids Health Dis; 2017 Apr; 16(1):82. PubMed ID: 28449683
[TBL] [Abstract][Full Text] [Related]
15. Involvement of sarco/endoplasmic reticulum calcium ATPase-mediated calcium flux in the protective effect of oleic acid against lipotoxicity in hepatocytes.
Ogino N; Miyagawa K; Kusanaga M; Hayashi T; Minami S; Oe S; Honma Y; Harada M
Exp Cell Res; 2019 Dec; 385(1):111651. PubMed ID: 31568762
[TBL] [Abstract][Full Text] [Related]
16. Hepatoprotective effect of bisbenzylisoquinoline alkaloid tiliamosine from Tiliacora racemosa in high-fat diet/diethylnitrosamine-induced non-alcoholic steatohepatitis.
Sylvester Darvin S; Toppo E; Esakkimuthu S; Ajeesh Krishna TP; Ceasar SA; Stalin A; Balakrishna K; Muniappan N; Pazhanivel N; Mahaprabhu R; Paulraj MG; Pandikumar P; Ignacimuthu S; Al-Dhabi NA
Biomed Pharmacother; 2018 Dec; 108():963-973. PubMed ID: 30372908
[TBL] [Abstract][Full Text] [Related]
17. Procyanidin B2 ameliorates free fatty acids-induced hepatic steatosis through regulating TFEB-mediated lysosomal pathway and redox state.
Su H; Li Y; Hu D; Xie L; Ke H; Zheng X; Chen W
Free Radic Biol Med; 2018 Oct; 126():269-286. PubMed ID: 30142454
[TBL] [Abstract][Full Text] [Related]
18. Alpha-naphthoflavone attenuates non-alcoholic fatty liver disease in oleic acid-treated HepG2 hepatocytes and in high fat diet-fed mice.
Xia H; Zhu X; Zhang X; Jiang H; Li B; Wang Z; Li D; Jin Y
Biomed Pharmacother; 2019 Oct; 118():109287. PubMed ID: 31401392
[TBL] [Abstract][Full Text] [Related]
19. Cellular glutathione in fatty liver in vitro models.
Garcia MC; Amankwa-Sakyi M; Flynn TJ
Toxicol In Vitro; 2011 Oct; 25(7):1501-6. PubMed ID: 21620948
[TBL] [Abstract][Full Text] [Related]
20. C/EBP homologous protein modulates liraglutide-mediated attenuation of non-alcoholic steatohepatitis.
Rahman K; Liu Y; Kumar P; Smith T; Thorn NE; Farris AB; Anania FA
Lab Invest; 2016 Aug; 96(8):895-908. PubMed ID: 27239734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
